Skip to content

AGENT™ H7493960815400Recalls & reported problems

Boston Scientific Corporation · Paclitaxel-Coated Balloon Catheter · Class 3

All models of AGENT (23)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00191506014773), received between May 5, 2025 and Aug 19, 2026 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 1 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Contamination1
  • Difficult to Advance1
  • Material Rupture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 19, 2026Break; Difficult to Advance

    It was reported that a shaft break occurred.The 90% stenosed target lesion was located in a moderately tortuous and severely calcified distal right coronary artery (RCA). A 4.00 mm x 15.00 mm Agent drug coated balloon (DCB) was selected for treatment. During the procedure, while the physician was advancing the balloon, it snapped at the mid shaft. The device was removed as a single unit, and the procedure was completed using a different device.It was further reported that the user encounter resistance while advancing the device. It was fractured on the balloon shaft. And there was no patient complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50334625 ↗
  • MalfunctionMay 12, 2026Material Rupture

    IT WAS REPORTED THAT A BALLOON RUPTURE OCCURRED. A 4.00 MM X 15.00 MM AGENT DRUG-COATED BALLOON (DCB) WAS SELECTED FOR A PERCUTANEOUS CORONARY INTERVENTION (PCI). DURING THE PROCEDURE, THE BALLOON RUPTURED. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25150240 ↗
  • MalfunctionMay 5, 2025Contamination; Contamination

    IT WAS REPORTED THAT CONTAMINATION OCCURRED. A 4.00 X 15MM AGENT DCB BALLOON WAS SELECTED FOR IN-STENT RESTENOSIS PERCUTANEOUS CORONARY INTERVENTION (ISR PCI) PROCEDURE. DURING PREPARATION, BALLOON BECAME CONTAMINATED ON THE FIELD AFTER OPENING. PROCEDURE WAS COMPLETED USING NEW AGENT DCB BALLOON AND NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21959887 ↗

Other Drug-eluting percutaneous transluminal coronary angioplasty catheter devices

All Drug-eluting percutaneous transluminal coronary angioplasty catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page